Product Reports Resources Pricing Login Book a demo

XtalPi

Biotech & Life Sciences · Shenzhen, China · Founded 2014 · IPO 2024

Artificial intelligence (AI) pharmaceutical firm

Valuation $2.75B
Revenue $112M
Power Law Unicorn$1–10B valuation tier

Talent graph

XtalPi's talent

Book a demo to see the people
Employees mapped 367 incl. 3 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

16 investors on XtalPi's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage
Tencent
ZhenFund
Renren
Series B+ 13 investors entered at this stage
Morningside Venture Partners
SoftBank
China Life Insurance
PICC Capital
5Y Capital
Sino Biopharmaceutical
RRJ Capital
Massachusetts Institute of Technology
SIG China
Sequoia
SoftBank Vision Fund
Alphabet | Google
OrbiMed

Global footprint

Where XtalPi has talent and traffic

Workforce by country
10 countries with
team presence
🇨🇳 China69.1%
🇺🇸 United States23.6%
🇭🇰 Hong Kong2.3%
🇨🇦 Canada1.6%
🇬🇧 United Kingdom1%
Top 5 of 10 shown
Web traffic by country
38K monthly visits
across markets
🇨🇳 China35.5%
🇺🇸 United States18.9%
🇳🇬 Nigeria11.3%
🇭🇰 Hong Kong7.1%
🇩🇪 Germany7.1%
Top 5 markets shown

Patent intelligence

$17M patent portfolio · 341 active families

Estimated portfolio value
$17M
0.60% of market cap · 41.9× larger than top peer Generate Biomedicines ($396k)
341 active patent families
Where XtalPi innovates Computer engineeringData miningIndustrial engineeringMaterials scienceMechanical engineering

Where XtalPi concentrates vs peers

Each axis is a top-10 topic across XtalPi and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

XtalPi's 19 investments and acquisitions.

Every disclosed deal where XtalPi appeared as a backer or acquirer, 2020–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

19 deals across XtalPi's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        XtalPi's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        19 of 19 deals

        Market sentiment

        What the market is saying about XtalPi

        An AI-synthesized read of the highest-engagement posts about XtalPi on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See XtalPi on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles